A5385

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

A5385 is a two-step non-interventional study for participants from qualifying ACTG and non-ACTG interventional cure trials (parent studies) that include an analytical treatment interruption (ATI) period who achieved prolonged viral control off antiretroviral therapy (ART) post-intervention (post-intervention control [PIC]) in their parent study.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 02 Apr 2026. Study ID: 25-2252
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research